A Study to Assess the Level of Stress, Anxiety and Depression Among Patients with Chronic Kidney Disease in Selected Hospitals, Hosur
Keywords:
Chronic kidney disease, depression, anxiety, stressAbstract
Background: Chronic kidney disease (CKD) is a major public health concern worldwide, affecting millions of individuals and posing significant challenges to healthcare systems. Methodology: The present study adopted a cross-sectional descriptive study. The sample size is estimated as 60 by using power analysis. The study will include patients aged 18 and above, who given informed consent and diagnosed with chronic kidney disease (CKD) currently receiving dialysis at the Gunam super specialty hospital, Hosur. Patients with severe cognitive impairment or unrelated mental health disorders and those in the acute stages of kidney failure will be excluded from the study. Results: The results show that 30.0% of patients experienced mild depression, 25.0% moderate depression, and 25.0% had no depression. For anxiety, 33.3% had mild anxiety, 30.0% moderate anxiety, and 20.0% had no anxiety. Severe depression, anxiety, and stress were less common, with 20.0%, 16.7%, and 20.0% reporting these conditions, respectively. There are strong positive correlations between depression, anxiety, and stress (r-values 0.72-0.83), with p-values less than 0.001, indicating statistically significant relationships. Conclusion: The study concluded that the there is a significant lack of BLS knowledge among laypersons, with most participants showing inadequate understanding and 80% unaware of BLS. The study highlights the sustained efforts are needed to improve BLS education and training, targeting both healthcare professionals and the general public, to enhance the community's ability to respond to cardiac emergencies and improve survival rates
Downloads
Metrics
References
Empagliflozin in patients with chronic kidney disease. (2023). New England Journal of Medicine, 388(2), 117-127. https://doi.org/10.1056/nejmoa2204233
Adejumo, O., Iyawe, I., Akinbodewa, A., Abolarin, O., & Alli, E. (2019). Burden, psychological well-being, and quality of life of caregivers of end-stage renal disease patients. Ghana Medical Journal, 53(3), 190. https://doi.org/10.4314/gmj.v53i3.2
Aftab, R., Khan, A., AbdulRazzaq, H., & Adnan, A. (2016). Acute ischemic stroke and acute on chronic kidney disease. Journal of Nepal Medical Association, 54(202), 85-87. https://doi.org/10.31729/jnma.2825
Aggarwal, H., Jain, D., Dabas, G., & Yadav, R. (2017). Prevalence of depression, anxiety, and insomnia in chronic kidney disease patients and their correlation with demographic variables. Prilozi, 38(2), 35-44. https://doi.org/10.1515/prilozi-2017-0020
Alkaabi, A., Alkous, A., Mahmoud, K., Almansoori, A., Elbarazi, I., Suliman, A., … & Al- Maskari, F. (2022). The prevalence and correlates of depression among patients with chronic diseases in the United Arab Emirates. PLOS One, 17(12), e0278818. https://doi.org/10.1371/journal.pone.0278818
Asano, K., Ogata, A., Tanaka, K., Ide, Y., Sankoda, A., Kawakita, C., … & Fukushima, M. (2014). Acoustic radiation force impulse elastography of the kidneys. Journal of Ultrasound in Medicine, 33(5), 793-801. https://doi.org/10.7863/ultra.33.5.793
Bautovich, A., Katz, I., Loo, C., & Harvey, S. (2018). Beck Depression Inventory as a screening tool for depression in chronic hemodialysis patients. Australasian Psychiatry, 26(3), 281-284. https://doi.org/10.1177/1039856218758582Fahad, M., Kandhro, A., & Khan, S. (2021). Screening of depression in chronic kidney disease patients undergoing hemodialysis. International Journal of Endorsing Health Science Research (IJEHSR), 9(3), 395-400. https://doi.org/10.29052/ijehsr.v9.i3.2021.395-400
Fatmawati, A., Soelaeman, M., & Rafiyah, I. (2018). The application of art therapy to reduce the level of depression in patients with hemodialysis. Belitung Nursing Journal, 4(3), 329-
https://doi.org/10.33546/bnj.407
Gerson, A., Wentz, A., Abraham, A., Mendley, S., Hooper, S., Butler, R., … & Furth, S. (2010). Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics, 125(2), e349-e357. https://doi.org/10.1542/peds.2009-0085
Guerra, F., Giacomo, D., Ranieri, J., Tunno, M., Piscitani, L., & Ferri, C. (2021). Chronic kidney disease and its relationship with mental health: Allostatic load perspective for integrated care. Journal of Personalized Medicine, 11(12), 1367. https://doi.org/10.3390/jpm11121367
Habib, O., Ashaq, F., Butt, N., Ashraf, H., Mahmood, K., & Anser, A. (2022). Prevalence of depression and anxiety in chronic kidney disease patients. PJMHS, 16(6), 236-238. https://doi.org/10.53350/pjmhs22166236
Hasnidar, .., Aswadi, M., & Putra, W. (2022). Family support and quality of life for chronic kidney disease (CKD) patients hemodialysis therapy at Undata Hospital. Journal of Health and Nutrition Research, 1(1), 6-10. https://doi.org/10.56303/jhnr.v1i1.3
Hassanien, A., Alshaikh, F., Vámos, E., Yadegarfar, G., & Majeed, A. (2012). Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: A systematic review. JRSM Short Reports, 3(6), 1-21. https://doi.org/10.1258/shorts.2012.011150
Hedayati, S., Gregg, L., Carmody, T., Jain, N., Toups, M., Rush, A., … & Trivedi, M. (2017). Effect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence. JAMA, 318(19), 1876. https://doi.org/10.1001/jama.2017.17131
Jiang, C., Zhu, F., & Qin, T. (2020). Relationships between chronic diseases and depression among middle-aged and elderly people in China: A prospective study from CHARLS. Current Medical Science, 40(5), 858-870. https://doi.org/10.1007/s11596-020-2270-5
Kim, O., Yeom, E., & Jeon, H. (2020). Relationships between depression, family function, physical symptoms, and illness uncertainty in female patients with chronic kidney disease. Nursing and Health Sciences, 22(3), 548-556. https://doi.org/10.1111/nhs.12691
Lin, L., Zhong, X., Huang, S., & Zhang, X. (2020). The effect of nutrition education on nutrition treatment of chronic kidney disease. Medical Research, 2(3), 20-24. https://doi.org/10.6913/mrhk.202009_2(3).0004
Maarse, B., Chesnaye, N., Schouten, R., Michels, W., Bos, W., Szymczak, M., … & Meuleman, Y. (2021). Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: Results of the EQUAL study. Clinical Kidney Journal, 15(4), 786-797. https://doi.org/10.1093/ckj/sfab261
Manns, B., Hemmelgarn, B., Lillie, E., Dip, S., Cyr, A., Gladish, M., … & Laupacis, A. (2014). Setting research priorities for patients on or nearing dialysis. Clinical Journal of the American Society of Nephrology, 9(10), 1813-1821. https://doi.org/10.2215/cjn.01610214
Ran, L. (2023). Impact of sarcopenia on prognosis in frail elderly patients with chronic kidney disease. Proceedings of Anticancer Research, 7(5), 35-40. https://doi.org/10.26689/par.v7i5.5261Rehman, A. (2024). The frequency of depression among patients with chronic kidney disease on hemodialysis. Journal of Islamabad Medical & Dental College, 13(1), 49-53. https://doi.org/10.35787/jimdc.v13i1.1006
Severino, R. (2024). Medical use of finererone in patients with diabetes mellitus and chronic kidney disease. Journal of Diabetes Metabolic Disorders & Control, 11(1), 6-8. https://doi.org/10.15406/jdmdc.2023.11.00269
Sharma, P., & Khatiwada, R. (2022). Level of depression in chronic kidney disease patients undergoing hemodialysis at Kathmandu District. International Journal of Health Sciences and Research, 12(2), 199-203. https://doi.org/10.52403/ijhsr.20220228
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.